Recalling that the levels are commonly very low in HDs and patients with BPH, our multivariate model employing uEVEpCAM-CD9, prostate tissue-specific protein (PSA), and other clinical parameters showed an enhanced diagnostic performance both in sensitivity and specificity. Here, CD9 is linked to benign prostatic hyperplasia.